Cover art for Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy
Article · Health & Wellness

Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy

Written by Andrej Belančić, Kristina Skroče, Elvira Meni Maria Gkrinia, Mihaela Marinović Glavić, Man Ki Kwok

47:34Cole16 tracks

Narration by Research @research
Listen free

About

This review explores clinical strategies to protect muscle mass and strength for patients undergoing treatment with GLP-1 receptor agonists. It provides actionable, evidence-informed guidance to help practitioners minimize sarcopenia risk during weight loss. From https://www.mdpi.com/2077-0383/15/15/5870. 2026. CCBY 4.0. Audio narration of original text.

#glp-1#weight loss#sarcopenia#muscle health#clinical practice#obesity management
Read the full text →

Contents

  1. 1Abstract1:24
  2. 21. Introduction3:05
  3. 31.1. Methods7:52
  4. 41.2. Sarcopenia Risk Identification and Baseline Assessment Prior to GLP-1-Based Therapy5:18
  5. 51.3. Lifestyle and Exercise Interventions for Sarcopenia Prevention0:04
  6. 61.3.1. Lifestyle Counseling as a Foundational Preventive Strategy1:50
  7. 71.3.2. Resistance Exercise as the Cornerstone Intervention1:14
  8. 81.3.3. Role of Aerobic and Multicomponent Physical Activity5:45
  9. 91.4. Nutritional Strategies and Monitoring of Muscle Health During GLP-1-Based Therapy0:06
  10. 101.4.1. Protein Intake Recommendations During GLP-1-Based Therapy4:16
  11. 111.4.2. Protein Quality, Timing, and Supplementation3:59
  12. 121.4.3. Micronutrients and Adjunct Nutritional Strategies2:33
  13. 131.5. Body Composition and Functional Monitoring During Treatment1:26
  14. 141.6. GLP-1 Dose Titration and Weight-Loss Pace Optimization1:42
  15. 152. Discussion6:19
  16. 163. Conclusions0:34